Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

For the first time, an individual has been seen publicly controlling an iPad entirely through thought, thanks to Apple's new brain-computer interface (BCI) protocol and Synchron's implantable ...

These are exciting times at the intersection of artificial intelligence (AI) and neuroscience. The trend in brain-computer interfaces (BCIs) is toward flexible and less invasive devices that can ...

Apple has partnered with brain-computer interface maker Synchron to develop tech that lets consumers control devices like iPhones with their thoughts, according to a report by the Wall Street Journal.

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...

When a new technology shows promise, performance-wise and commercially, innovation does not stop. To the contrary, it gathers pace. New medical devices typically emerge from competing groups of ...

Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...